Quantinno Capital Management LP grew its position in Envista Holdings Co. (NYSE:NVST - Free Report) by 54.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 86,056 shares of the company's stock after acquiring an additional 30,264 shares during the quarter. Quantinno Capital Management LP owned 0.05% of Envista worth $1,660,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of NVST. Franklin Resources Inc. lifted its position in shares of Envista by 72.6% in the 4th quarter. Franklin Resources Inc. now owns 6,854,506 shares of the company's stock worth $132,223,000 after acquiring an additional 2,882,844 shares during the period. Norges Bank bought a new stake in shares of Envista in the 4th quarter valued at approximately $38,052,000. Dimensional Fund Advisors LP raised its holdings in shares of Envista by 19.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 6,762,091 shares of the company's stock worth $130,440,000 after buying an additional 1,089,923 shares in the last quarter. Deerfield Management Company L.P. Series C lifted its position in shares of Envista by 4,949.9% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 1,018,415 shares of the company's stock worth $19,645,000 after buying an additional 998,248 shares during the period. Finally, Pzena Investment Management LLC acquired a new stake in Envista in the 4th quarter valued at $16,979,000.
Analyst Ratings Changes
Several research analysts have issued reports on NVST shares. Bank of America dropped their price objective on Envista from $26.00 to $23.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. New Street Research set a $19.00 target price on shares of Envista in a research report on Thursday, March 6th. Morgan Stanley set a $16.00 price target on shares of Envista in a report on Tuesday, April 15th. Needham & Company LLC reaffirmed a "hold" rating on shares of Envista in a research note on Thursday, March 6th. Finally, UBS Group cut their target price on shares of Envista from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Monday, May 5th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, Envista currently has an average rating of "Hold" and a consensus target price of $20.08.
Check Out Our Latest Stock Report on Envista
Envista Price Performance
NVST traded down $0.14 during trading on Friday, hitting $16.73. The company's stock had a trading volume of 2,062,553 shares, compared to its average volume of 2,562,804. The firm's 50 day moving average price is $16.57 and its two-hundred day moving average price is $18.85. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. Envista Holdings Co. has a 12 month low of $14.22 and a 12 month high of $23.00. The stock has a market capitalization of $2.84 billion, a price-to-earnings ratio of -2.58, a price-to-earnings-growth ratio of 1.27 and a beta of 0.97.
Envista (NYSE:NVST - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.20 by $0.04. The company had revenue of $616.90 million during the quarter, compared to analysts' expectations of $608.17 million. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. The business's revenue for the quarter was down 1.1% on a year-over-year basis. During the same period last year, the firm earned $0.26 EPS. Sell-side analysts forecast that Envista Holdings Co. will post 1 earnings per share for the current fiscal year.
About Envista
(
Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Recommended Stories
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
